Development and evaluation of a novel digital therapeutic for adults with post-traumatic stress disorder
Active Project Grant Awarded Last action
- Award ID
- R44MH136888
- Recipient
-
OUI Therapeutics Inc. UEI U4K6RELD5F16
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,099,056
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date 47% complete
- Originally
- Place of performance
- Florida, USA
Award details come from USAspending.gov.
Description
- Abstract
- Post-traumatic stress disorder (PTSD) is a chronic, debilitating health problem that affects 4.7% of adults in the US and has a total economic cost of $232.2 billion, annually. Effective evidence-based treatments exist but are underutilized. Substantial barriers to receiving proven cognitive-behavioral treatments include cost, time, difficulty finding qualified clinicians, and perceived stigma. Thus, IT is critical to develop novel therapeutics that overcome these obstacles and increase widespread accessibility to effective treatment for PTSD. To this end, this fast track project aims to develop OTX-601, a mobile APP, digital therapeutic to treat PTSD. During phase I, we will develop a usable APP, determine the optimal dose, and determine the feasibility, acceptability, and usability of OTX-601. We will also conduct a pilot randomized controlled trial (RCT) to determine the preliminary efficacy of OTX-601 in treating PTSD. During phase II, we will conduct an RCT to determine the effectiveness of OTX-601 in treating PTSD. Positive results will be the critical initial step for facilitating the widespread implementation and commercialization of the digital therapeutic to enhance access to highly personalized PTSD intervention.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $966,804 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $417,356 | |
| Amendment | $417,356 | |
| Amendment | $417,356 | |
| Amendment | $440,092 | |
| Original award | $440,092 |
Quick answers
Who received award R44MH136888?
R44MH136888 was awarded to OUI Therapeutics Inc. by National Institute of Mental Health (National Institutes of Health) on June 5, 2024.
How much is award R44MH136888 worth?
$3,099,056 has been obligated on R44MH136888.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award